Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
Jeffrey J. Wallin, David F. McDermott(Beth Israel Deaconess Medical Center)
Cited by 708
Related Papers
<scp>PD</scp>‐1 as a potential target in cancer therapy
|Cancer Medicine|2013|409